This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
Medicines for Malaria Venture (MMV) is a not-for-profit public-private partnership that was established as a foundation in Switzerland in 1999. Its main mission is to reduce malaria in disease-endemic countries by developing and facilitating the delivery of antimalarial drugs.
History edit
MMV was launched in 1999, with initial seed funding of US$4 million from the Government of Switzerland, the Department for International Development (UK), the Government of the Netherlands, the World Bank, and the Rockefeller Foundation.
Governance edit
MMV is governed by a board of directors. The Chairman of MMV is Mr Alan Court.[1] MMV has a board of directors in North America, an Expert Scientific Advisory Committee which helps to identify projects, an Access & Product Management Advisory Committee and a Global Safety Board which reviews projects.[2]
Projects edit
MMV's project portfolio states that their goals are:
- Effective treatment against drug-resistant strains of Plasmodium falciparum
- The potential for intermittent treatments (infants and pregnancy)
- Safety for small children (less than 6 months old)
- Safety in pregnancy
- Effective treatment against Plasmodium vivax (including radical cure)
- Effective treatment against severe malaria
- and transmission-blocking treatment.
Open Source Malaria edit
MMV started the Open Source Malaria project,[3] which encourages people to share procedures and results of open source research.[4] The Open Source Malaria, with researchers at the University of Sydney, supervised high school students at Sydney Grammar School who adapted a synthesis of Daraprim (pyrimethamine) using a less hazardous method.[5][6]
References edit
- ^ "Board of Directors | Medicines for Malaria Venture". www.mmv.org. Archived from the original on 1 May 2024. Retrieved 12 December 2022.
- ^ "People & governance | Medicines for Malaria Venture". www.mmv.org. Archived from the original on 1 May 2024. Retrieved 12 December 2022.
- ^ "OpenSourceMalaria". OpenWetWare. 14 May 2017.
- ^ "OpenSourceMalaria:FAQ". OpenWetWare.
- ^ University of Sydney (30 November 2016). "Breaking good: School students make costly drug cheaply using open source approach". Eurekalert.
- ^ Knopf, Ehsan (1 December 2016). "Sydney high school students spend $27 to recreate drug that has retailed for $148k". 9news.com.au.